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Abstract
Intercellular communication within the bone marrow niche signiﬁcantly promotes leukemogenesis and provides
protection of leukemic cells from therapy. Secreted factors, intercellular transfer of mitochondria and the
receptor–ligand interactions have been shown as mediators of this protection. Here we report that tunneling
nanotubes (TNTs)—long, thin membranous structures, which have been identiﬁed as a novel mode of intercellular
cross-talk—are formed in the presence of stroma and mediate transfer of cellular vesicles from stroma to leukemic
cells. Importantly, transmission of vesicles via TNTs from stromal cells increases resistance of leukemic cells to the
tyrosine kinase inhibitor, imatinib. Using correlative light-electron microscopy and electron tomography we show that
stromal TNTs contain vesicles, provide membrane continuity with the cell bodies and can be open-ended. Moreover,
trans-SILAC studies to reveal the non-autonomous proteome showed that speciﬁc sets of proteins are transferred
together with cellular vesicles from stromal to leukemic cells, with a potential role in survival and adaptation.
Altogether, our ﬁndings provide evidence for the biological role of the TNT-mediated vesicle exchange between
stromal and leukemic cells, implicating the direct vesicle and protein transfer in the stroma-provided protection of
leukemic cells.
Introduction
Chronic myeloid leukemia (CML) results from a reci-
procal chromosomal translocation, which gives rise to a
bcr-abl fusion gene1. The BCR-ABL1 protein is a con-
stitutively active tyrosine kinase capable of uncontrolled
signaling to numerous downstream targets2. Since the
introduction of imatinib3,4, the annual mortality rate has
decreased signiﬁcantly5. This therapy is successful in the
chronic phase of disease, however most patients either do
not achieve a complete cytogenetic response or develop
resistance and progress to the blast phase. Importantly,
cells that are isolated and cultured in vitro often lose their
chemoresistant phenotype, suggesting a cytoprotective
role of the bone marrow microenvironment6. The stroma-
provided protection of CML cells from imatinib treatment
has been well documented7–9. Additionally, we and others
have shown that stromal and leukemic cells interact
bidirectionally, to support leukemogenesis10–12. Overall,
intercellular communication is an important player in the
stroma-mediated resistance of CML. However, our
understanding of how stromal cells inﬂuence leukemia is
still incomplete.
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Tunneling nanotubes (TNTs) or membrane nanotubes
are long, thin membranous structures that connect dis-
tant cells, ﬁrst characterized as open membrane con-
duits13. However, some types of membrane immune
synaptic nanotube were also discovered to contain a
submicron scale junction, or synaptic connection,
enabling transfer of cargo14–17. Recent studies using cor-
relative cryo-electron microscopy showed 3D ultra-
structure of TNTs in neuronal cells18 however most of
studies failed to establish a clear structure for TNTs.
TNTs or membrane nanotubes more broadly, have been
recognized as a novel mode of intercellular communica-
tion19–21, enabling transfer of cellular vesicles13,15, mito-
chondria22–25, miRNAs26, viral particles17 and single
proteins27,28. They have been found in variety of cell types:
immune cells14,15, neurons29, endothelial cells30,31 or
mesenchymal stromal cells 32.
In cancer cells, TNTs formation might correlate with
invasion33,34. Moreover, TNT-mediated mitochondria
transfer has been shown to promote chemoresis-
tance26,35,36. Recently, TNTs have been also found in
blood cancers and within their microenvironment. Acute
myeloid leukemia cells have been shown to form homo-
typic TNTs37 as well as heterotypic ones with bone
marrow cells38. The latter resulted in transfer of mito-
chondria toward AML cells, suggesting a survival advan-
tage. Acute lymphoid leukemia cells signal to
mesenchymal stromal cells through TNTs, promoting
secretion of proleukemic cytokines39. Recent studies
showed that the HTLV-1 transmission between leukemic
cells occurs via TNTs37. Together, these studies are
consistent with leukemic cells using multiple TNT-
dependent processes. Even if TNT-mediated vesicles
transfer has been shown in leukemia, the in-depth studies
of the functional consequences of cellular vesicles transfer
within leukemia microenvironment are lacking. Here, we
report evidence for the direct trafﬁc of vesicles via TNTs
from stromal to CML cells providing protection against
imatinib-induced apoptosis. Speciﬁc functional sets of
proteins with possible roles in survival and adaptation
were directly transferred together with vesicles. Moreover,
using CLEM tomography we showed the ultrastructure of
stromal TNTs. Altogether, these studies indicate TNT-
mediated vesicle and protein transfer as important players
in the stroma-provided protection of leukemia.
Materials and methods
Cell lines and reagents
K562 (ATCC#CCL-243) and HS-5 (ATCC#CRL-11882)
cell lines were cultured in RPMI medium that was sup-
plemented with 10% fetal bovine serum (FBS), 1% L-glu-
tamine, and 1% penicillin streptomycin. Both cell lines
were recently been authenticated by the ATCC Cell Line
Authentication Service, using Short Tandem Repeat
(STR) analysis, and underwent a regular screen for
Mycoplasma contamination by RT-PCR. The K562-GFP
cell line was established by Dr. M. Kusio-Kobiałka. Ima-
tinib was a generous gift from the Pharmaceutical
Research Institute (Warsaw) and used at concentrations
of 0.5, 1, and 2 µM.
Co-culture system and ﬂow cytometry measurements
Exchange of cargo between cells
Donor cells were labelled with DiD (catalog no. V22887,
ThermoFisher Scientiﬁc), 1.5 μl/1 ml of cell culture
medium for 15 min at 37 °C, washed and plated in fresh
cell culture medium for an additional 16 h. To analyze
mitochondria transfer, HS-5 cells were transduced with
rLV.EF1.AcGFP1-mito-9 lentiviral vector (TaKaRa) for
stable mitochondria labelling. Afterward, cells were see-
ded in co-culture with acceptor cells in 12-well cell cul-
ture plates (1 × 105 HS-5 cells plus 0.8 × 105 K562 wt or
K562-GFP cells) to reach a 1:1 ratio after 24 h. For ﬂow
cytometry BD LSRFortessa cytometer (Becton Dickinson
Poland) was used, followed by data analysis using Diva
and FlowJo software.
Transwell and CM controls
To physically separate donor and acceptor cells in co-
culture, HS-5 and K562 cells were plated in the lower and
upper chambers of a transwell system (ThinCert, Greiner
Bio-One), 1 µM pores, 2 × 106 pores/cm2, for 24 h. As a
control for the conditioned media (CM), donor cells were
labeled as described above. After 24 h, the supernatant
was collected, centrifuged to remove cells and cellular
debris, and added to acceptor cells in 12-well culture
plates. After another 24 h, acceptor cells underwent ﬂow
cytometry analysis.
Flow cytometry measurement of apoptotic cells
Co-cultures of DiD-labeled HS-5 cells with K562 GFP
cells were untreated or treated with imatinib for 24 h and
stained with AnnexinV-PE and 7-AAD (catalog no.
559763, BD Pharmingen) according to the manufacturer’s
instructions. DiD+ and DiD− acceptor cells were sepa-
rated by gating and analyzed for apoptosis. To study
caspase activation, cells were labeled with Violet Live Cell
Caspase Probe (catalog no. 565521, BD Pharmingen)
according to the manufacturer’s instructions and 7-AAD
for live cell discrimination. DiD+ and DiD- acceptor cells
were separated by gating, and the percentage of cells with
active caspases was calculated. For ﬂow cytometry BD
LSRFortessa cytometer was used, followed by data ana-
lysis using Diva and FlowJo software.
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Fluorescent imaging and live cell microscopy
Immunocytochemistry and immunoﬂuorescence
Cells were plated on poly-L-lysine-coated coverslips,
ﬁxed with 4% paraformaldehyde, permeabilized with 0.1%
Triton X-100, blocked with 5% FBS and incubated with
antibodies and ﬂuorescent stains. Phalloidin (Thermo-
Fisher Scientiﬁc) was used for actin staining, DAPI (cat-
alog no. D9542, Sigma-Aldrich) was used for nuclear
labeling. Microtubules were labeled with monoclonal
anti-β-tubulin antibody (catalog no. T0198, Sigma-
Aldrich), MyoVa antibody, (catalog no. 3402S, Thermo-
Fisher Scientiﬁc), MyoVI antibody (catalog no. 25–6791,
Proteus), and MyoVIIa antibody (catalog no. 25–6790,
Proteus). Mitochondria and cellular vesicles were labeled
with 250 nMMitoTracker Deep Red (catalog no. M22426,
ThermoFisher Scientiﬁc) or DiD, respectively. Images
were acquired using a Zeiss LSM 780 microscope with a
63× objective and further processed using ImageJ and
Imaris software.
Tunneling nanotube imaging in living cells
HS-5 and K562 cells expressing GFP were plated on
poly-L-lysine coated Lab-Tek Chamber Slides (Thermo-
Fisher Scientiﬁc). Plasma membranes were labeled with
Wheat Germ Agglutinin (WGA) conjugates: WGA-AF
647 (catalog no. W32466, ThermoFisher Scientiﬁc) or
WGA-AF 488 (catalog no. W11261, ThermoFisher Sci-
entiﬁc). Images were acquired using an SP8 Leica
microscope with a ×63 or ×100 objective. For TNTs
quantiﬁcation ten ﬁelds (155 μm× 155 μm) with z-stacks
that covered the majority of the cell volume were acquired
using SP8 Leica microscope with a 63× or 100× objective.
The data were manually analyzed using ImageJ software
with the Cell Counter plugin.
Plasma membrane contribution
K562 cells were transfected by nucleofection (Amaxa
Nucleofector Technology, Lonza AG) using a GPI-GFP
plasmid (kind gift from D. Davis). After 24 h cells were
sorted based on GFP ﬂuorescence and co-cultured with
HS-5 cells on Lab-Tek Chamber Slides (ThermoFisher
Scientiﬁc) for 48 h. Additionally, both cell types were
stained with WGA-Alexa Fluor 647 (ThermoFisher Sci-
entiﬁc). Images were acquired using an SP8 Leica




Cells were plated on poly-L-lysine-coated coverslips.
After 48 h, cells were ﬁxed with 2.5% glutaraldehyde and
2% PFA, followed by washing with PBS, water and dehy-
dration by subsequent incubation in an ascending series
of ethanol concentrations (50%, 70%, 96%, and 99.9%,
10 min each). Then samples were subjected to critical-
point drying, gold-coated, and imaged on 3View using
Zeiss Sigma VP SEM column. The secondary electron
signal was used to obtain an image.
Transmission electron microscopy and CLEM tomography
Monolayers of cells were seeded on IBIDI-gridded, glass
window, poly-L-lysine-coated plates (Grid-500 Glass
Bottom μ-Dish, 35 mm (81168, Ibidi). After 24 h, cells
were labeled with WGA AF-647 and ﬁxed in 2.5% glu-
taraldehyde and 2% PFA in cacodylate buffer. Light
microscopy images were acquired using Olympus IX81
wideﬁeld microscope (Olympus Germany) with CellR
software. Cells were then washed with cacodylate, con-
trasted in 1% osmium and 1% uranyl acetate (UA),
dehydrated in ethanol, and embedded in Epon resin. The
ﬁxation, contrasting, and dehydration steps were per-
formed in a PELCO Biowave Pro microwave40. 50 serial
sections (300 nm thick) were collected on formvar-coated
slot grids, 15 nm gold beads were added as ﬁducial for
tomogram reconstruction, and then sections were post-
stained in 2% UA and lead citrate. Regions of interest
(ROI) were imaged using a FEI Tecnai F30 (tomography)
electron microscope (300 kV). Tomograms were acquired
using combination of Tecnai FEI and SeriaEM softwares.
Pixel size 26nm, magniﬁcation 4700x, series of images was
taken between −60 and +60 degree using double tilt grid
holder. Images were acquired with a OneView Camera
(Gatan). Tomogram reconstruction processing was per-
formed using the IMOD software package41.
M-Sec silencing
The MISSION® TRC shRNA bacterial stock containing
shRNA plasmids targeting M-Sec (TNFAIP2) (Sigma-
Aldrich) have been streaked onto a plate and plasmids
were isolated by use of Endo Free Maxi Prep kit (Qiagen)
after single colony inoculation and overnight culture.
Isolated plasmids were veriﬁed by restriction enzyme
analysis. For viral vector production the Human
Embryonic Kidney cells (HEK 293T) cultured in low
glucose DMEM (catalog no. 6046, Sigma-Aldrich), sup-
plemented with 10% FBS and 1% penicylin/streptomycin
were transiently co-transfected with 3 plasmids contain-
ing elements necessary for lentiviral vector production
(pVSV—pseudotyping plasmid encoding the vesicular
stomatitis virus envelope; pΔ8.2—encapsidation plasmid
and pMISSION® TRC shRNA plasmid containing the
shRNA construct). The polyethylenimine PEI (MW ~ 25
000; Warrington) transfection method was used. Twenty-
four hours post transfection the target K562 cells were
added and viral infection was performed by 72 h co-
culturing of packaging cells and target cells in presence of
Polybren (Sigma-Aldrich), ﬁnal concentration 10 μg per
ml. After infection the non-adherent K562 cells were
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gently removed, centrifuged and resuspended in RPMI
medium with 1 µg/ml selection antibiotic Puromycin
(Sigma-Aldrich). M-Sec protein level was estimated by
Western Blotting using antibody anti-TNFAIP2 alpha (M-
Sec) (catalog no. sc-28318, Santa Cruz).
Trans-SILAC
Cell labeling with heavy isotopologues of lysine and arginine
The SILAC medium was supplemented with 10% of
dialyzed FBS, 1% Pen/Strep, 0.274mM L-lysine, and
1.15mM L-arginine and ﬁltered (0.22 µM pores). Donor
cells were labeled with heavy isotopologues of lysine and
arginine: L-lysine:2HCL (13C6, 99%; 15N2, 99%) and L-
arginine: HCL (13C6, 99%; 15N4, 99%; Cambridge Isotope
Laboratories, Sigma-Aldrich). Cells were maintained in the
appropriate medium for 9 days to enable complete labeling
of the proteome. The medium was changed every 2–3 days.
On day 8, donor cells were labeled with DiD as described
above. This experiment was performed in duplicate.
Co-cultures and cell sorting
Twenty-four hour co-cultures were sorted using a BD
FACSAria sorter (Becton Dickinson Poland). GFP ﬂuor-
escence was excited with a 488-nm laser, and emission
was detected with a 530/30 ﬁlter. DiD ﬂuorescence was
excited with a 633-nm laser, and emission was detected
with a 660/20 ﬁlter. Donor and acceptor cells were
separately gated, followed by sorting of acceptor cells into
two subpopulations: positive and negative for transferred
vesicles (DiD+ vs DiD-). Cell pellets were immediately
frozen in liquid nitrogen and stored at −80 °C until fur-
ther sample preparation.
Sample preparation
Cell pellets were lysed in 25mM ammonium carbonate
and 0.1% Rapigest (pH 8.2). Protein lysate (10 μg) was
digested with Trypsin Gold, reduced with 5mM tris(2-
carboxyethyl) phosphine (TCEP), and blocked with 5mM
iodoacetamide. DID+ and DID− samples were diluted
with 4× Laemmli buffer, boiled for 5 min at 95 °C, and
loaded onto a sodium dodecyl sulfate-polyacrylamide
electrophoresis gel. Lanes were cut into six pieces, and
proteins were digested using trypsin according to stan-
dard protocols42. Peptides were extracted, puriﬁed by
styrenedivinylbenzene reverse-phase sulfonate (SDB-RP);
also known as mixed mode chromatography stage tips43,
and stored at 4 °C prior to MS analysis.
LC-MS/MS analysis
Mass spectrometry analysis was performed using an EASY
nLC 1000 coupled to a Q-Exactive Plus mass spectrometer
(ThermoFisher Scientiﬁc). Peptides were separated by a
180-min linear gradient of 95% solution A (0.1% formic acid
in water) to 35% solution B (acetonitrile and 0.1% formic
acid). The measurement of each sample was preceded by
three washing runs to avoid cross-contamination. The mass
spectrometer was operated in the data-dependent MS-MS2
mode. Data were acquired in them/z range of 300–1750 at a
nominal resolution of 70,000.
Data were analyzed using the Max-Quant 1.5.3.12
platform, with the reference human proteome database
from UniProt. False discovery rates of protein and
peptide-spectrum matches (PSM) levels were estimated
using the target-decoy approach at 0.01% (protein FDR)
and 0.01% (PSM FDR), respectively. The minimal peptide
length was set to 7 amino acids, and carbamidomethyo-
lation at cysteine residues was considered a ﬁxed mod-
iﬁcation. Oxidation (M) and Acetyl (Protein N-term) were
included as variable modiﬁcations. Only proteins that
were represented by at least two unique peptides in two
biological replicates are shown and were further con-
sidered. The data analysis was performed using Max-
Quant software and the MaxLFQ algorithm
(Supplementary Table 1). Lists of proteins were analyzed
using the Panther application for GeneOntology soft-
ware44, STRING-conﬁdence view45, and Venny 2.1
(http://bioinfogp.cnb.csic.es/tools/venny/index.html).
Additionally, lists of proteins were grouped according to
their molecular weights based on the UniProt database.
The mass spectrometry data from this publication have
been deposited to the ProteomeXchange Consortium via
the PRIDE [https://www.ebi.ac.uk/pride] partner reposi-
tory with the dataset identiﬁer PXD013504.
Statistical analysis
All of the experiments were performed in at least three
independent biological repetitions, trans-SILAC has been
done in two biological replicates. All of the data are
presented as mean ± SEM. Student’s t-test with Welch
correction was used to test differences between two
conditions. Values of p < 0.05 were considered statistically
signiﬁcant. Microsoft Excel and GraphPad Prism software
were used for the data analysis. *p < 0.05, **p < 0.01, ***p <
0.001.
Results
Tunneling nanotubes are formed between CML and
stromal cells
To investigate the formation and function of TNTs
within the leukemia microenvironment, we ﬁrst set out to
test whether or not HS-5 cells, a model bone marrow
stromal cell line8,46 and K562 chronic myeloid leukemia
cells, are able to form intercellular connections with
characteristics of TNTs. Using confocal microscopy fol-
lowed by 3D reconstruction (Fig. 1a) and scanning elec-
tron microscopy (SEM) (Fig. 1b) we conﬁrmed the
efﬁcient formation of TNT connecting two distant cells.
We found that TNTs are membrane structures which do
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Fig. 1 (See legend on next page.)
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not touch the substratum (Fig. 1a). All TNTs contained F-
actin, whereas tubulin was present only in some (Sup-
plementary Fig. 1). The time-lapse studies of viable cells
revealed that stromal TNTs were formed within minutes
after direct cell-cell contact followed by cell dislodgement
(Fig. 1c, Supplementary Movie 1). In contrast to stromal
TNTs, homotypic TNTs formed between CML cells were
very rare and relatively short, however they also displayed
features representative for TNTs (Fig. 1d).
To examine the formation of heterotypic TNTs, GFP-
positive K562 cells were co-cultured with HS-5 stromal
cells. Staining of membranes in living cells revealed the
presence of structures with TNT features that connected
distant cells of two types (Fig. 1e, g). Heterotypic TNTs
did not touch the substratum (Fig. 1e, g) and were formed
also by cell dislodgement (Fig. 1f, Supplementary Movie
2). In living cells, the average length and diameter of
heterotypic TNTs did not differ signiﬁcantly from
homotypic stromal TNTs (Fig. 1 h).
To assess whether plasma membranes of both cell types
participate in the formation of heterotypic TNTs, CML
cells expressed GFP with a GPI tag to track plasma
membrane, in addition to staining of all plasma mem-
branes with WGA-Alexa Fluor 647. We found that
membranes from either only one type or originated from
both cell types build heterotypic TNTs (Supplementary
Fig. 2a), and the length of TNTs did not depend on the
plasma membrane origin (Supplementary Fig. 2b).
Calculation of the average number of TNTs per 100
cells (TNT index) showed that only 1.0 ± 0.6 TNTs
among 100 CML cells were found at a given time, in
comparison to 150.0 ± 32.0 TNTs formed by 100 stromal
cells (Fig. 1i, left panel). Upon contact with stroma, CML
cells formed more TNTs (TNT index increased up to
35.0 ± 6.0) (Fig. 1i, left panel). The heterotypic TNTs
generally accounted for 16.5% ± 3.5% of all TNTs, whereas
homotypic CML TNTs constituted only 1.8% ± 1.0% of
the overall number (Fig. 1i, middle panel). The presence
of stromal component increased leukemic TNTs,
increasing not only TNT index (Fig. 1i) but also number
of nanotubes per cell (Fig. 1j). Altogether, our analysis
revealed that heterotypic TNTs are formed between
stromal and leukemic cells and the stroma component
stimulates formation of TNTs by leukemia.
CLEM analysis of TNT ultrastructure of stromal cells
Having shown that heterotypic TNTs formed between
stromal and CML cells resemble those between stromal
cells, according to similar size, structure and mechanism
of formation, we went on to examine their ultrastructure.
To assess the 3D ultrastructure TNTs we used CLEM and
electron tomography followed by 3D reconstruction (Fig.
2a). Single TNTs were observed already upon resolution
of ﬂuorescence microscopy (Fig. 2b). EM tomography
conﬁrmed that single TNT was a tube, continuous with
the plasma membrane of the cell body (Fig. 2b, c). The
thickness of the TNTs was remarkably consistent
(~200 nm). However, apart from single TNTs described
above, we also observed bunches of multiple TNTs (Fig.
2d), which were similar to those described in neurons18,
indicating that both forms are possible within the leu-
kemic stroma. Importantly, the open-ended TNTs were
found, conﬁrming possibility of cargo transfer between
two distant cells (Fig. 2c, yellow arrows), however also
possibly close-ended TNTs were observed (Fig. 2c, black
arrow). Membrane vesicles with an average diameter
corresponding to the typical size of cellular vesicles
(111 ± 33 nm) were present inside TNT lumen (Fig. 2e).
Typically, nanotube bulges were seen in places con-
taining vesicles (Fig. 2e). Together with the presence of
(see ﬁgure on previous page)
Fig. 1 Formation of tunneling nanotubes (TNTs) between leukemic cells and stromal cells. a Representative image of TNTs that interconnected
stromal cells (left) and 3D reconstruction (right). Cell membranes were stained with WGA-Alexa Fluor 488. Scale bar= 4 μm. b Scanning electron
microscopy image of TNTs formed between stromal cells. Zoomed images show a TNT end that protruded from the cell body and a bifurcation of
the TNT. Scale bars: 10 μm (left image), 2 μm (middle and right images). c Selected frames from a time-lapse experiment (h:min:sec) that presents TNT
formation between stromal cells. Cell membranes were stained with WGA-Alexa Fluor 647. d Representative images showing a TNT formed between
leukemic cells visible after cell membranes staining with WGA-Alexa Fluor 488 (left) and after scanning electron microscopy (right). Scale bar= 10 μm.
e Representative image of heterotypic TNTs that interconnected one stromal cell and two CML cells (left) and 3D reconstruction (right). CML cells
were labeled with DiD (red) and all cell membranes were stained with WGA-Alexa Fluor 488 (green) directly before imaging. Scale bar = 4 μm. f
Selected frames from a time-lapse experiment (h:min:sec) that presents TNT formation between stromal and CML cells. Red indicates all cell
membranes that were stained with WGA-Alexa Fluor 647. Green indicates CML cells that expressed cytoplasmic GFP. Scale bars= 10 μm g Scanning
electron microscopy image of TNTs formed between stromal cells and CML cells. Zoomed images show that TNT ends protruded from cell bodies of
stromal and CML cells. Scale bars= 2 μm. h Diameters and lengths of homo- and heterotypic TNTs that were measured in living cells by confocal
microscopy. Homotypic TNT formed by stromal cells (HH) or leukemic cells (KK) as well as heterotypic TNTs (HK) were measured. i Average numbers
of TNTs per 100 cells quantiﬁed in mono- and co-culture set-ups by confocal microscopy after 24 h of cell culture. The graph (left) shows that stromal
cells had a propensity to form TNTs, whereas CML cells were prone to form TNTs only upon co-culture with stromal cells. Prevalence of homo- and
heterotypic TNTs in a co-culture set-up, quantiﬁed by confocal microscopy. The diagram (right) shows that the majority of TNTs that were found in
co-cultures were homotypic TNTs that interconnected stromal cells. Heterotypic TNTs constituted a considerable portion of overall TNTs. CML cells in
co-culture were signiﬁcantly more involved in TNT formation with stromal cells than in TNT formation with other CML cells. j Percentage of CML cells
that exhibited a given number of TNTs in a monoculture (upper) and co-culture (lower) set-up
Kolba et al. Cell Death and Disease          (2019) 10:817 Page 6 of 16
Ofﬁcial journal of the Cell Death Differentiation Association
structures resembling actin ﬁlaments that were
observed in TNT containing vesicles (Fig. 2e, right
panel), these are consistent with cellular vesicles being
trafﬁcked via TNTs.
Cellular vesicles are transferred between stromal and CML
cells in TNT-promoting conditions
To dissect the process of vesicular transfer between
cells, we quantiﬁed the movement of bulges along TNTs
Fig. 2 Ultrastructure of tunneling nanotubes (TNTs). a The workﬂow of serial section CLEM tomography used to visualize 3D ultrastructure of
stromal TNTs. b Correlative light and c electron microscopy (CLEM) of the same area from 300 nm sections were imaged by bright ﬁeld b (upper) and
ﬂuorescence microscopy (lower; WGA—stained). View of corresponding tomography stack visible of marked ROI (purple and green frames) showing
the presence of TNTs with open ends providing continuity with the cell body (yellow arrows). Possibly closed TNT is indicated with black arrow. Scale
bar= 20 μm (b), 2 μm (c—upper left), 500 nm (c—bottom left and right). d Fluorescence image of one thick TNT (left) and tomography of ROI (green
frame) showing the bunches of single TNTs. Scale bar= 2 μm (left image), 500 nm (middle and right images). e Transmission electron microscopy
(left) of the TNT with visible bulge (left, blue frame) with corresponding electron tomography view show cellular vesicles present inside a TNT. Scale
bar= 500 nm
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(Figs. 3a, b, Supplementary Movie S3). As the speed
movement was similar to that reported for myosin-driven
movement47,48, the presence of myosins was assessed.
MyoVa, MyoVI, and MyoVIIa were detected along F-actin
containing TNTs (Fig. 3c), suggesting their possible
involvement. In order to visualize myosins within thin
TNT, the signal had to be increased resulting in
overexposure of cellular ﬂuorescence. To directly visualize
cargo, organelles were speciﬁcally tracked. MitoTracker-
stained mitochondria were evident within TNTs (Fig. 3d),
consistent with transfer of mitochondria via TNTs49.
Cellular vesicles were labelled with DiD, which stains
lipophilic structures with very low toxicity, does not
undergo passive transport and has been used to track
Fig. 3 Visualization of cargo transfer mediated by tunneling nanotubes (TNTs) formed between stromal cells. a Frames from a time-lapse
experiment that present the transport of two bulges along a TNT. Scale bar= 4 μm. b Velocity of cargo transfer in the time-lapse experiments (n= 18
events). c Representative images that show the presence of molecular motors inside TNTs. Green indicates the actin cytoskeleton. Blue indicates
nuclei. Red indicates antibody-stained myosin Va (left), myosin VI (middle), and myosin VIIa (right). Scale bar= 5 μm. Single channels and a merged
image are shown. d Representative images that show the presence of mitochondria inside TNTs (left panels). Green indicates actin. Blue indicates
nuclei. Red indicates mitochondria that were stained with MitoTracker Deep Red. The 3D reconstruction shows in detail mitochondria that were
present within the lumen of the TNT (right panels). Scale bar= 4 μm. e Representative image that shows the presence of cellular vesicles inside TNTs
(left panels). Green indicates cell membranes that were stained with WGA-Alexa Fluor 488. Red indicates cytoplasmic vesicles that were stained with
DiD. The 3D reconstruction shows in detail cytoplasmic vesicles that were present within the lumen of the TNT (right panels). Scale bar= 4 μm
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cellular vesicles transferred by different ways, including
TNTs15,50–52. DiD-tracked vesicles were present inside
TNTs (Fig. 3e) consistent with our EM data.
To assess the efﬁciency of mitochondria intercellular
transport, we adapted ﬂow cytometry (Fig. 4a), previously
used to quantify the nanotube-mediated vesicles trans-
fer14,52. The TNT-mediated transfer of stromal GFP-
expressing mitochondria, (Supplementary Fig. 3a), was
conﬁrmed by a transwell, estimated as a percentage of
GFP-positive leukemic acceptor cells (Supplementary Fig.
3b) and visualized (Supplementary Fig. 3c).
Next, HS-5 cells possessing DiD-tracked vesicles were
co-cultured with CML cells expressing GFP, to distin-
guish stromal donors from leukemic recipients15,49–51. In
this case we quantiﬁed vesicles accumulated during 24 h
of transfer, shown as a percentage of DiD-positive (DiD+)
Fig. 4 (See legend on next page.)
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acceptor cells (Fig. 4a). Interestingly, the transfer efﬁ-
ciency depended on the donor cell type (Fig. 4b). In
mono-cultures, stromal cells were efﬁcient donors,
whereas CML cells were very poor donors (Supplemen-
tary Fig. 4, Fig. 4b, c). In co-culture, transfer from stromal
to leukemic cells was signiﬁcantly more efﬁcient (Fig. 4b,
c). The Pearson’s correlation of the level of TNT cargo
transfer with the counts of TNTs further indicated that
TNTs might be responsible for the vesicles trafﬁcking
(Fig. 4d).
To exclude that secretion of extracellular vesicles could
underlie the transfer observed by ﬂow cytometry, acceptor
cells were cultured in the 24 h conditioned medium (CM)
of donor cells that were labeled with DiD (Fig. 4e). The
transfer of vesicles in CM-treated acceptor cells was
substantially lower than the transfer that occurred under
co-culture conditions allowing direct cell-cell contact and
TNT formation (Fig. 4e, CM). To further assess the role of
cell-cell contact, necessary for TNT formation, acceptor
cells were physically separated from donor cells by a
transwell with 1.0 µM pores which enabled cells to share
the same media (containing exosomes and other extra-
cellular vesicles) but excluded the possibility of physical
direct contact. Transfer of dye was signiﬁcantly lower in
the transwell conditions compared to co-culture (Fig. 4e).
M-Sec protein has been proposed as a regulator of TNT
formation in macrophages34,53 and in U2OS osteo-
sarcoma cell line54. To test whether M-Sec is a general
regulator of TNTs, M-Sec expression was silenced in HS-
5 and K562 cells (Supplementary Fig. 5a, b). TNT-
mediated vesicle transfer was not affected by M-Sec
silencing (Supplementary Fig. 5c). This suggests that M-
Sec does not regulate vesicle transfer from stroma to
leukemia and indicates that M-Sec function as TNT dri-
ver might be cell-type speciﬁc. Given that M-Sec deple-
tion could not be used to verify the involvement of TNTs
in intercellular cargo transfer, we instead subjected co-
cultures to starvation, previously reported to stimulate the
formation and activity of TNTs35. Indeed, starvation
upregulated vesicle trafﬁcking from stroma to leukemia
(Supplementary Fig. 5d). Altogether, these data establish
that the stroma-to-leukemia intercellular vesicle transfer
occurs in TNT-promoting conditions, is cell-to-cell
contact-dependent and is not mediated by secreted
extracellular vesicles.
Direct transfer of cellular vesicles from stroma protects
CML cells from imatinib-induced apoptosis
The TNT-mediated transfer of vesicles has been
described previously but crucially, biological con-
sequences of such transfer have not been established. As
CML cells are protected from imatinib-driven apoptosis
upon co-culture with stromal cells55,56 (Supplementary
Fig. 6), we addressed whether or not TNT-mediated
transfer of vesicles confers this protection. DiD-stained
stromal cells were co-cultured with CML cells treated
with imatinib. Apoptosis was detected separately in sub-
populations of CML acceptor cells, that received (DiD+)
or did not (DiD-) receive ﬂuorescent vesicles from stroma.
We found that uptake of vesicles from stroma correlated
with increased protection against imatinib-driven apop-
tosis (Fig. 5a), visible as signiﬁcantly lower percentage of
Annexin V-staining in DiD+ CML cells, compared with
CML cells negative for vesicles (DiD−). In addition,
activity of effector caspases -1, -2, -3, -6, -8, -9, and -10 in
imatinib-treated leukemic cells was signiﬁcantly lower in
the DiD+ population (Fig. 5b). On the other hand,
mitochondrial transfer was not upregulated after 24 h, and
slightly upregulated after 48 h of imatinib treatment,
however, the percentage of recipient leukemic cells was
still very low (below 4%) indicating that mitochondrial
transfer is probably not a crucial rescue mechanism in
imatinib response (Supplementary Fig. 6b). Altogether,
these data are consistent with direct transfer of cellular
(see ﬁgure on previous page)
Fig. 4 Quantitative analysis of the direct exchange of cellular vesicles between stromal and leukemic cells. a Dot plots that present the
gating strategy for the ﬂow cytometry experiments on the exchange of cellular vesicles in a co-culture set-up. CML cells expressed cytoplasmic GFP.
Donor cells were labeled with DiD for cytoplasmic vesicles. The plots depict the shift in ﬂuorescence in acceptor cells that was caused by the uptake
of ﬂuorescently labeled vesicles. The transwell system was used as a control to show that vesicles transfer was directly contact-dependent. b Time
course of cellular vesicle trafﬁcking in the mono- and co-culture set-ups, quantiﬁed by ﬂow cytometry. The percentage of DiD+ acceptor cells is
shown. Statistical signiﬁcance marked in the stroma-stroma transfer was compared to stroma-CML (**), CML-stroma (ΔΔΔ) and CML-CML (ΟΟΟ)
transfer; marked in the stroma-CML transfer was compared to stroma-stroma (***), CML-stroma (ΔΔΔ) and CML-CML (ΟΟΟ) transfer; marked in the
CML-stroma transfer was compared to stroma-stroma (***), stroma-CML (ΔΔΔ) and CML-CML (ΟΟΟ) transfer; marked in the CML-CML transfer was
compared to the stroma-stroma (***), stroma-CML (ΔΔΔ) and CML-stroma (ΟΟΟ) transfer. c Efﬁciency of cellular vesicle trafﬁcking in the mono- and
co-culture set-ups, quantiﬁed by ﬂow cytometry and presented as the average percentage of acceptor cells that received ﬂuorescently labeled
vesicles that were transferred from donor cells after 24 h of culture. Statistical signiﬁcance was calculated between indicated values. d The Pearson’s
correlation calculated for efﬁciency of vesicles transfer and TNT index. e Control experiments for TNT-promoting conditions of the stroma-leukemia
vesicles transfer. Donor cells were labeled with DiD for cytoplasmic vesicles. For the control experiments, (i) a transwell system was used to physically
separate donor and acceptor cells that shared the same medium, or (ii) acceptor cells were cultured in conditioned medium (CM) that was collected
from donor cells, to allow for exchange of secreted but not directly transferred vesicles. The percentage of DiD+ acceptor cells is shown. Statistical
signiﬁcance was calculated to co-culture control. All of the data are expressed as the mean ± SEM of three independent experiments
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vesicles from stromal to leukemic cells being important
for acquiring protection from imatinib-induced apoptosis.
Speciﬁc sets of proteins are transported with vesicles from
stroma to leukemia
We hypothesized that the stroma-dependent protection
of leukemic cells might result from proteome exchange
that occurs together with TNT-dependent transfer of
vesicles. To identify proteins which are directly trans-
ferred between HS-5 stromal and K562 CML cells toge-
ther with vesicles, we used mass spectrometry (MS)-based
trans-SILAC, combined with ﬂuorescent vesicle tracking
with DiD and cell sorting (Fig. 6). Donor stromal cells
were cultured in media containing heavy isotopologues of
lysine and arginine to allow for >98.5% incorporation
(Supplementary Table 2) and additionally stained for
vesicles with DiD. Then co-cultured with acceptor cells
and followed by sorting of GFP-positive CML cells posi-
tive (DiD+) or negative (DiD−) for the stroma-derived
vesicles. Liquid chromatography-tandem MS enabled to
identify heavy-labeled proteins within the proteome of
acceptor cells. These proteins were expressed in donor
cells and transferred with vesicles to acceptor cells during
co-culture.
We identiﬁed 481 donor-derived proteins in the K562
DiD− population and 646 in the K562 DiD+ population
(Supplementary Table 3), with 351 proteins in common
(Fig. 7a). 294 proteins (DiD+ exclusive) were transferred
exclusively to leukemia cells together with DiD-tracked
vesicles. Similar molecular weight distribution (Fig. 7b),
demonstrated that regardless of the transport mechanism,
there was no obvious size restriction.
Statistical overrepresentation analysis against the refer-
ence set showed that within the DiD- exclusive group of
proteins, no biological processes were enriched, whereas
in the DiD+ exclusive group, proteins involved in trans-
lation initiation and mRNA splicing were speciﬁcally
enriched (Fig. 7c). This corresponded to the STRING
analysis of DiD+ exclusive proteins, showing a functional
protein-protein interaction net (Fig. 7d; PPI enrichment p
< 1.0e−16). Two major hubs in the network contained
proteins involved in mRNA processing and translation or
the mRNA catabolic process. These results suggested that
cellular vesicles transferred in a TNT-promoting condi-
tions to CML cells, might serve as a source of proteins to
modulate gene expression at the level of mRNA proces-
sing and translation in CML cells.
Next, the complete DiD+ and DiD− lists of proteins
were compared after a statistical overrepresentation test.
GeneOntology analysis identiﬁed 15 biological processes
that were enriched exclusively in the DiD+ sample (Fig. 7e,
Supplementary Table 4). Already identiﬁed regulation of
mRNA splicing, RNA localization, RNA metabolic pro-
cesses and translation, but also novel ones: negative reg-
ulation of apoptotic signaling, cell redox homeostasis, and
response to drug, were strongly overrepresented in the
DiD+ group (Fig. 7e, Supplementary Table 4). Thus, the
proteins transported via TNTs and enriched speciﬁcally in
leukemic cells which obtained stromal vesicles might
speciﬁcally promote survival and response to stress con-
ditions. Altogether, our data show the novel mechanism
of stroma-provided protection of CML cells from imati-
nib, involving direct transfer of cellular vesicles and pro-
teins. To our knowledge this is the ﬁrst evidence
indicating the biological role of vesicles transferred from
stroma to leukemia via tunneling nanotubes.
Discussion
The present study provides new insights into the stroma-
provided protection of leukemic cells and highlights the
important role of a direct cell-to-cell trafﬁcking of cellular
vesicles and proteins that can support the cytoprotective
and anti-apoptotic responses of leukemic cells; with TNTs
likely being involved in the observed exchange.
Fig. 5 Protection of leukemic cells from imatinib-induced apoptosis by the transported vesicles. a Percentage of apoptotic leukemic cells
upon treatment with imatinib, analyzed separately for cells that received (DiD+) or did not receive (DiD-) cellular vesicles from stromal cells. b
Percentage of leukemic cells with active caspases upon treatment with imatinib, analyzed separately for cells that received (DiD+) or did not receive
(DiD-) cellular vesicles from stromal cells. Statistical signiﬁcance was calculated between indicated values. All of the data are expressed as the mean ±
SEM of three independent experiments
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The presence of leukemic TNTs has been reported
previously37,39,49,57 although their formation within leu-
kemia microenvironment is not well explored. Here, we
present evidence that TNTs formed between stromal and
CML cells facilitate transfer of mitochondria, cellular
vesicles and proteins. The presence of stroma stimulated
leukemic cells to form TNTs, consistent with previous
work showing that AML cells isolated from bone marrow
formed more TNTs, than cells without stromal compo-
nent37. Leukemia-stroma TNTs were shown also to
regulate cytokines secretion39 and mediate mitochondrial
transfer49.
To date, no speciﬁc molecular markers of TNTs have
been uncovered. Hence, the presence of characteristic
morphological features is required to identify TNTs19,58.
Here, we conﬁrmed that membrane connections formed
between leukemic cells and stroma possess features to be
classiﬁed as TNTs. We excluded the possibility that they
are ﬁlopodia-like protrusions, or adhesive gap-junctions,
previously described in leukemia59. We also established
that TNT formation occurs between these cell types fol-
lowing “cell dislodgement”14,60,61. A similar process has
been reported for immune cells14,15,62 and cells of other
origin63.
There is still a limited data describing the 3D ultra-
structure of TNTs. Recently, the ﬁrst Cryo-EM studies of
neuronal TNTs were published18. Here, we performed
CLEM and electron tomography 3D ultrastructure ana-
lysis of stromal TNTs. We were able to detect single tubes
by CLEM, after single TNT detected by ﬂuorescent
microscopy. We also observed thicker TNTs, which were
revealed to be bunches of multiple TNTs, as recently
found between neurons18. Thus, either single TNTs or
TNT bunches can be formed within bone marrow stroma.
There is much debate as to whether or not nanotubes
may possess open or closed ends and form a synaptic
connection. Here, we provide evidence that TNTs can
have both: some TNTs seem to have open ends while
others can be closed. Similar indications were noticed also
for neuronal TNTs18. Detection of intercellular transfer of
cargo, provided a functional proof for existence of open
structures binding two distant cells enabling transfer. We
propose that both types representing open- and close-
ended TNTs can exist simultaneously. The possibility that
TNTs are indeed highly dynamic, open-close structures,
cannot be excluded, but needs advanced studies providing
the 3D reconstruction of the very same TNT, combined
with life imaging studies.
Importantly, no general pharmacological inhibitors of
TNT activity have been discovered to date. Hence, the
only possibility to provide evidence that the observed
cargo transfer is TNT-mediated is to perform indirect
experimental veriﬁcations. Thus, using different micro-
scopic approaches, as well as the transwell and condi-
tioned medium controls we provided indirect, however
complex correlative data, conﬁrming that the stroma to
leukemia vesicle transfer, occurs exclusively in TNT-
promoting conditions. Such approach has been used by
others to imply TNT involvement24. Our data showing
that M-Sec silencing does not have impact on TNTs
formation in leukemic microenvironment are in agree-
ment with similar observations in AML cells37. Hence,
our data are consistent with vesicle transfer from stromal
to leukemic cells being mediated via TNTs.
Fig. 6 The scheme showing the mass spectrometry (MS)-based
trans-SILAC approach performed to identify proteins that are
present within stroma-derived vesicles. Donor stromal cells were
cultured in media containing heavy isotopologues of Lys and Arg for
9 days to allow complete incorporation of these amino acids into their
proteome. They were stained with DiD for cellular vesicles and
subjected to co-culture with acceptor CML cells for 24 h. Afterwards
two subpopulations of CML cells were sorted using FACS: cells which
received (DiD+) or did not receive (DiD-) cellular vesicles from donor
stromal cells. In both samples, heavy proteins transferred from donor
stromal cells, were identiﬁed. Only proteins present exclusively in the
DiD+ sample were considered to have been transferred along with
the studied vesicles
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Crucially, we found that TNT-mediated transfer of
vesicles from stroma correlates with the protection of
leukemic cells from imatinib-induced apoptosis.
Exchange of vesicles has been previously described, but
mostly as a proxy to studying TNT formation, rather than
to address speciﬁc functional consequences13,52. It was
proposed previously that receiving mitochondria in a
TNT-dependent way, may be a potent mechanism of
survival49. Also, TNT-dependent secretion of proleu-
kemic cytokines39, transfer of oncogenes33 and miRNAs26
can not be neglected as part of the tumor-stromal cross-
talk and potent regulators of oncogenic signaling in
acceptor cells. Our data indicate that TNT-mediated
transfer of cellular vesicles from stroma is a novel cyto-
protective mechanism participating in leukemia
resistance.
Interestingly, we found that functional sets of proteins
can be transferred together with vesicles from stromal to
leukemic cells. The transfer of single proteins via TNTs
has been reported24,64, however, we demonstrated that
whole sets of proteins can be exchanged between cells.
Identiﬁed proteins can form functional networks to reg-
ulate biological processes that are important for cyto-
protection. We propose that they either directly help
CML cells cope with drug response/apoptosis or indir-
ectly remodel their proteome at the levels of transcription
and translation to promote adaptation and survival. As a
general ﬁnding, our data support the hypothesis of
intercellular proteome exchange65,66.
Altogether, our data are in line with others, indicating
TNTs as promising therapeutic target in cancer. Despite
detection of different inhibitory compounds, the speciﬁc
TNT inhibitors are still not developed20. Different stra-
tegies to inhibit TNTs formation and function are pro-
posed, including those inhibiting microﬁlament
formation67, mTOR pathway or vesicular transport con-
trolled by the small Rab GTPases68. This data rather
suggest that there are multiple TNT formation pathways,
which are selectively expressed depending on cellular
context20. So, even if targeting of TNTs is promising and
opens up novel possibilities for therapies, challenges still
remain.
In summary, we described the ultrastructure of stromal
TNTs and present evidence for TNT-transferred vesicles
in the protection of leukemic cells. Thus, TNT-mediated
cross-talk may be crucial to the stroma-provided imatinib
resistance, and if so, then TNT-mediated communication
would be a potential therapeutic target in the treatment of
leukemia.
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Fig. 7 Identiﬁcation of proteins transported along with cellular vesicles from stromal to leukemic cells. a Venn diagram comparison of sets of
proteins that were transferred from stromal to CML cells either separately (DiD-) or together with DiD-labeled cellular vesicles (DiD+). b Molecular
weights of proteins that were transferred from stromal to CML cells separately (DiD-) or together with DiD-labeled cellular vesicles (DiD+). c Results of
statistical overrepresentation test of the DiD+ exclusive list of proteins (Panther GeneOntology). The list was tested for the enrichment of proteins
that are involved in GeneOntology Biological Processes against the reference list of genes of the K562 cell line from the PRIDE database, completed
with the list of genes that were identiﬁed in the present study. Fisher’s Exact with FDR multiple test correction was used. Only results with FDR ≤ 0.05
are presented. d Analysis of functional protein association networks (String software) of the DiD+ exclusive list of proteins. Nodes represent proteins.
Edges represent protein-protein associations. The line thickness indicates the strength of data support. PPI enrichment p < 1.0e−16. e Enriched
biological processes Gene Ontology term analysis of proteins that were transferred along with DID-labelled cellular vesicles (DiD+)
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